Radiation plus immunotherapy shows promise in advanced cancers

NCT ID NCT03313804

First seen Mar 15, 2026 · Last updated Jun 12, 2026 · Updated 9 times

Summary

This study looked at 76 people with advanced non-small cell lung cancer or head and neck squamous cell cancer who were already starting immunotherapy. Within two weeks of their first dose, they received a short course of radiation to one tumor site. The goal was to see if this combination could improve the number of patients whose cancer did not get worse after six months, compared to historical data. The approach aims to help the immune system recognize and attack the cancer more effectively.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • University of Kentucky Markey Cancer Center

    Lexington, Kentucky, 40536, United States

Conditions

Explore the condition pages connected to this study.